Evidence map›Paper›PMID 42374519›Full record

ReviewJournal of cardiothoracic surgery2026

Secondary prevention of recurrent ischemic stroke: from guidelines to precision medicine.

Shiyang Liu, Siat Yee Fong, Hui Liu, Peiyang Sun

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shiyang LiuDepartment of Neurology, The Second Affiliated Hospital of Anhui, University of Traditional Chinese Medicine, Hefei, Anhui, P. R. China.
Siat Yee FongDepartment of Neurology, The Second Affiliated Hospital of Anhui, University of Traditional Chinese Medicine, Hefei, Anhui, P. R. China. siatyee@ums.edu.my.
Hui LiuDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Jalan UMS, Kota Kinabalu, Sabah, 88400, Malaysia.
Peiyang SunDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Jalan UMS, Kota Kinabalu, Sabah, 88400, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent ischemic stroke remains a major global health challenge, accounting for substantial disability and mortality despite advances in acute management. Secondary prevention has undergone a fundamental paradigm shift-from standardized, population-based regimens toward individualized, mechanism-targeted precision medicine. This review integrates evidence from recent AHA/ASA and ESO guidelines

Indexed as

Ischemic StrokePractice Guidelines as TopicPrecision MedicineSecondary PreventionAnticoagulantsHumansPlatelet Aggregation InhibitorsRecurrenceAnticoagulantsPlatelet Aggregation InhibitorsDirect oral anticoagulantDual antiplatelet therapyEmbolic stroke of undetermined sourceIschemic strokeLipid-lowering therapyPrecision medicineSecondary prevention

Identifiers

PMID42374519
PMCPMC13579900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.